(Source: Johnson & Johnson) Partnerships Announced with PEPFAR, Clinton Health Access Initiative, and International Partnership for Microbicides NEW BRUNSWICK, NJ - December 1, 2015 - Building on its 25-year legacy in the fight against HIV/AIDS, Johnson & Johnson today announced four new public-private partnerships through its Janssen Pharmaceutical Companies to significantly reduce the burden of HIV incidence, especially among adolescent girls, who make up 74 percent of new HIV infections among adolescents in sub-Saharan Africa[1]. Announced on World AIDS Day, these new initiatives include collaborations with the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the Clinton Health...
↧